Invitro International IVRO

$0.07 +0.01 (21.53%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
336,200
Avg volume
41,164
Day's range
$0.06 – $0.09
Shares out
—
Stochastic %K
41%
Beta
—
Analysts
—
Price target
—

Price

Company profile

InVitro International, Inc. Develops and markets test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembr...

Show more

InVitro International, Inc. Develops and markets test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services. Its products are principally used in cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation industries. InVitro International, Inc. was incorporated in 1985 and is headquartered in Placentia, California.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
800 246 8487
Website
https://www.invitrointl.com
Address
330 East Orangethorpe Avenue, Suite D, Placentia, United States

Latest news

No headlines yet.